The global potassium channel blocker market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Potassium channel blockers are a class of drugs that act by blocking potassium efflux through cell membranes, including inorganic ions (Cs, Ba) and organic molecules (TEA, 4-AP), toxins such as scorpion venoms, snake venoms, and bee venoms), and potassium channel blockers in clinical use. Thus, the growing application of potassium channel blockers in the medical field is likely to drive its global market growth. Adding to this, the promising opportunities associated with these channel blockers hold in the treatment of disorders such as obstructive sleep apnea and multiple sclerosis, among others, which is further projected to drive the market growth in the future years.

The market is broadly segmented based on type and application. Based on type, the market is sub-categorized into clinical, non-clinical, and inactive. Further, based on the application, the market is sub-categorized into clinics, hospitals, and others. Based on the type, the clinical sub-segment is anticipated to register significant growth. This growth is backed by the growing use of clinical potassium channel blockers in various drug trials as well as research. Another key trend to drive the segmental growth includes the promising result of potassium channel blockers for the treatment of patients suffering from multiple sclerosis.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Bristol-Myers Squibb Co., Sanofi S.A., and AstraZeneca plc, among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Potassium Channel Blocker Market Report by Segment

By Type

• Clinical
• Non-Clinical
• Inactive

By Application

• Clinic
• Hospital
• Others

Global Potassium Channel Blocker Market by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa